Company: IMCR
Filing Date: 2025-03-17
Form Type: 424B7
Source: 0001140361-25-008917
Chunk: 138

Company: Immunocore Holdings plc
Filing Date: 2025-03-17
Form: 424B7
Chunk 138
---
 our business without infringing, misappropriating or otherwise violating the intellectual property rights of others; |

| • | our expectations regarding competition with respect to KIMMTRAK or any of our other current or future product candidates, as well as innovations by current and future competitors in our industry; |

| • | our expectations regarding regulatory developments in the United States and other countries, including potential changes in healthcare laws and regulations; |

| • | our financial performance and our ability to effectively manage our anticipated growth; |

| • | our ability to identify, recruit and retain qualified employees, including key commercial or management personnel; |

| • | whether we are classified as a passive foreign investment company, or PFIC, for current and future periods; |

| • | our anticipated use of any net proceeds from offerings of our securities under this prospectus; and |

| • | any other factors discussed under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our most recent Annual Report on Form 10-K and in our subsequent Quarterly Reports on Form 10-Q for the quarterly periods ended subsequent to our filing of such Annual Report on Form 10-K, as well as any amendments or updates to our risk factors reflected in subsequent filings with the SEC, which are incorporated by reference into this prospectus, together with other information in this prospectus, the documents incorporated by reference, any prospectus supplement and any free writing prospectus that we may authorize. |

You should refer to the important factors in the cautionary statements included in this prospectus and in the other documents incorporated herein for a discussion of important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Unless required by law, we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law, applicable regulations or the rules of any stock exchange to which we are subject. You should read this prospectus, any applicable